Biotech

All Articles

Relay loses interest in SHP2 inhibitor after Genentech leaves

.3 full weeks after Roche's Genentech unit bowed out an SHP2 prevention treaty, Relay Therapy has ac...

Stoke's Dravet disorder med released of partial scientific grip

.Stoke Therapies' Dravet syndrome medicine has been freed from a partial hold, removing the method f...

Fierce Biotech's Gabrielle Masson shows Strong 15 at NYSE

.Fierce Biotech Colleague Publisher Gabrielle Masson showed the 2024 training class of Fierce 15 win...

Daiichi pays Merck $170M to develop bronchi cancer cells T-cell engager treaty

.Merck &amp Co. has rapidly made back several of the expenses of its Spear Rehabs purchase, attracti...

BioMarin halts preclinical gene therapy for heart condition

.After BioMarin conducted a spring tidy of its pipeline in April, the firm has chosen that it also n...

Eisai vegetations molecular glue SEED with $1.5 B biobucks deal

.Significant Pharmas remain caught to the suggestion of molecular adhesive degraders. The current pr...

Life science credit history agency introduces along with $600M

.A brand new international lifestyle science credit scores agency, called Symbiotic Funding, has act...

BMS trenches TIGIT, leaving $200M bank on Agenus bispecific

.Bristol Myers Squibb is axing another large wager from the Caforio age, canceling a deal for Agenus...

Nuvation standstills BET prevention after considering period 1 data

.After having a look at stage 1 data, Nuvation Biography has actually made a decision to stop focus ...

' Clinical intuition' led FDA advisors to back Zevra's rare ailment med

.Zevra Therapeutics' unusual health condition drug appears to be on the path to authorization this l...